Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.
about
Role of Staphylococcus aureus Virulence Factors in Inducing Inflammation and Vascular Permeability in a Mouse Model of Bacterial EndophthalmitisOptimization of airborne endotoxin exposure assessment: effects of filter type, transport conditions, extraction solutions, and storage of samples and extractsAntibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivitiesAntibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis.Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.Differential tumor necrosis factor alpha expression and release from peritoneal mouse macrophages in vitro in response to proliferating gram-positive versus gram-negative bacteria.A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage.Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiotaModulation of inflammatory response of wounds by antimicrobial photodynamic therapyCombined Systems Approaches Reveal a Multistage Mode of Action of a Marine Antimicrobial Peptide against Pathogenic Escherichia coli and Its Protective Effect against Bacterial Peritonitis and EndotoxemiaApplications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
P2860
Q27305290-ACCFC5CA-C207-4198-92AA-F59ACB69EBCEQ28397149-AAB62FFD-9209-4585-92D1-CC4E1796C657Q33702626-FD10DA39-4EE5-4F8A-A104-B3659DE9A664Q33794000-BD56FF82-45E6-4E8C-8B10-8C4C395B74DEQ33981143-A9E1D70D-071F-4EFE-BFA2-F46EBE700BF7Q33983134-FB88F3F1-BC08-4FFA-8EFC-D3F36072FE58Q34007548-1279F51E-B034-404A-845E-52A0CA21D16CQ34097875-69BC8483-E4BC-4AE5-A262-0A61C4073062Q34487226-3E7C6654-C5B7-4BCF-A793-293448664A8BQ34647328-0BFC28BE-559A-4941-B289-D5AED0F6A2F2Q35838221-9DC20200-DB5B-4722-B571-FCCB1F1AF3DDQ37538672-50C7E210-9B49-4813-9618-4BCF27A26791Q50016951-646CA9A9-1B1D-407C-A66D-9317AE7F988C
P2860
Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Antibiotic-induced lipopolysac ...... d imipenem and release of LPS.
@en
Antibiotic-induced lipopolysaccharide
@nl
type
label
Antibiotic-induced lipopolysac ...... d imipenem and release of LPS.
@en
Antibiotic-induced lipopolysaccharide
@nl
prefLabel
Antibiotic-induced lipopolysac ...... d imipenem and release of LPS.
@en
Antibiotic-induced lipopolysaccharide
@nl
P2093
P2860
P1476
Antibiotic-induced lipopolysac ...... d imipenem and release of LPS.
@en
P2093
J T van Dissel
K M Kwappenberg
P H Groeneveld
P van Langevelde
P2860
P304
P407
P577
1998-04-01T00:00:00Z